Year: 2020
Language: English
Author(s): World Federation of Hemophilia
Listen to this patient-focused 60-minute webinar, presented on June 16, 2020 at the World Federation of Hemophilia (WFH) Virtual Summit, to get a preview of two of the recommendations resulting from the ASH ISTH NHF ISTH WFH 2021 VWD Guidelines. Learn why international clinical guidelines are particularly important to this community, how they were developed, and the important contributions of various stakeholders throughout this process.
Paula James, Mark Skinner, Nathan Connell, Veronica Flood, and Reem Mustafa discuss the international VWD Guidelines for the bleeding disorder community patients and healthcare professionals alike.
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.
Listen to this 90-minute webinar presented on September 21, 2023 to learn about von Willebrand disease (VWD) in low-resource settings.
This edition is available in: English, Spanish, French The previous edition is also available in: Arabic, Russian, Simplified Chinese, Japanese
The previous edition is also available in: Japanese The previous edition of this resource has also been translated into the
In these sessions from the WFH 2022 World Congress, listen to Peter Lenting, Magdy El Ekiaby, Nathan Connell, Brooke Sadler,
In this session from the WFH 2020 Virtual Summit, Dawn Rotellini, Paula James, Jeannette Cesta, Cody Kester & Baiba Ziemele
In this session from the WFH 2020 Virtual Summit, Jill Johnsen, Michael Laffan & Jameela Sathar discuss von Willebrand disease
